Robot-Assisted Immersive Escape Room Game for Tobacco Harm Prevention Among Elementary School Students

March 24, 2026 updated by: National Taiwan Normal University

Effectiveness of a Robot-Assisted Immersive Escape Room Game for Tobacco Harm Prevention Among Fifth- and Sixth-Grade Elementary School Students

This study evaluates the effectiveness of a robot-assisted immersive escape room intervention for tobacco harm prevention among upper-grade elementary school students. A total of 200 fifth- and sixth-grade students from elementary schools in New Taipei City, Taiwan, will participate in this quasi-experimental, parallel-group design. Participants will be allocated non-randomly to either the experimental group, which receives the robot-assisted immersive escape room intervention, or the active comparator group, which receives standard classroom-based tobacco harm prevention education.

In the experimental arm, an educational robot named "Anti-Smoking Kebbi" serves as a non-player character (NPC) to facilitate human-robot interaction through puzzle-solving and scenario-based learning focused on e-cigarette and tobacco hazards. Both groups will be assessed using validated questionnaires at three time points: baseline (pre-intervention), immediately post-intervention, and 1-month follow-up. Primary and secondary outcome measures will include changes in tobacco harm knowledge, health beliefs, smoking refusal self-efficacy, extended expectation confirmation, learning engagement, behavioral intention, and advocacy intention.

Study Overview

Detailed Description

This study investigates the effectiveness of a robot-assisted immersive escape room game for tobacco harm prevention among elementary school students. The intervention integrates human-robot interaction and gamified learning to enhance students' understanding of e-cigarette and tobacco-related health risks.

A quasi-experimental parallel-group design will be used. Approximately 200 fifth- and sixth-grade students from elementary schools in New Taipei City, Taiwan will participate. Schools will be assigned to either the experimental group or the control group based on matched characteristics such as school size and location.

Students in the experimental group will participate in a 60-minute robot-assisted immersive escape room activity. The educational robot "Anti-Smoking Kebbi" acts as a non-player character (NPC) guiding students through puzzle-solving tasks related to tobacco harm prevention. The control group will receive a standard classroom-based tobacco harm prevention lesson delivered by trained teachers.

Data will be collected using structured questionnaires administered at baseline, immediately after the intervention, and at one-month follow-up. Outcomes include tobacco harm knowledge, health beliefs, smoking refusal self-efficacy, , extended expectation confirmation, learning engagement, behavioral Intention, and advocacy Intention will be assessed using structured questionnaires at baseline, immediately after the intervention, and at one-month follow-up.

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Xindian District
      • New Taipei City, Xindian District, Taiwan, 231040
        • Shuangfeng Elementary School, New Taipei City

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Fifth or sixth grade students from elementary schools in New Taipei City

Age 10-12 years

Written consent from parent/guardian

Verbal assent from student

Able to understand Chinese questionnaires

Exclusion Criteria:

  • Prior participation in tobacco harm education trials

History of tobacco-related allergies

Unable to complete questionnaires

Parental refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Robot-Assisted Immersive Escape Room Intervention
Students participate in a 60-minute robot-assisted immersive escape room intervention designed to prevent e-cigarette use. The program uses the "Anti-Smoking Kebbi" robot as a non-player character (NPC) to guide students through interactive puzzles and scenario-based tasks that teach the health risks of e-cigarette use and strategies for tobacco prevention.
Students participate in a 60-minute robot-assisted immersive escape room designed to prevent e-cigarette use. The session is facilitated by the educational robot "Anti-Smoking Kebbi," which acts as a non-player character (NPC) guiding students through interactive puzzles and scenario-based challenges. The activity integrates human-robot interaction and gamified learning strategies to teach the health risks of e-cigarette use and tobacco prevention concepts. The intervention is delivered once in a classroom setting.
Active Comparator: Traditional Tobacco Harm Prevention Education
Students receive a 60-minute traditional health education session on tobacco and e-cigarette harms delivered by trained teachers using lectures, slides, and classroom discussion, consistent with standard school-based health education practices.
Students receive a 60-minute standard classroom-based health education session on tobacco and e-cigarette harms delivered by trained teachers. The session uses lectures, presentation slides, and guided discussion to introduce the health risks of tobacco and e-cigarette use and strategies for prevention. The intervention is delivered once in a classroom setting.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Tobacco Harm Knowledge
Time Frame: Baseline (pre-intervention), immediately post-intervention, and 1-month follow-up
This study adapted the Tobacco Harm Knowledge Scale from the Youth Smoking Behavior Survey Questionnaire (Health Promotion Administration, 2021). The scale covers e-cigarette components, legal regulations, and health impacts to assess students' understanding of basic tobacco knowledge gained from the curriculum. The 10-item scale uses objective scoring (1 point for correct answers, 0 points for incorrect or "don't know" responses) and demonstrates acceptable internal consistency (Cronbach's Alpha = 0.66).
Baseline (pre-intervention), immediately post-intervention, and 1-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Health Beliefs About Tobacco Use
Time Frame: Baseline, immediately post-intervention, and 1-month follow-up.

This study adapted the scale from Kueh, M. T. W., Rahim, F. F., & Rashid, A. (2022). The questionnaire uses a 5-point Likert scale ranging from "Strongly Disagree" to "Strongly Agree." It begins with students' recognition of tobacco harm risks, such as "Smoking increases the risk of lung cancer" or "Smoking causes changes in appearance," to measure the strength of students' health beliefs and their awareness of smoking-related harms.

The 12-item scale employs a 5-point scoring system, with higher scores indicating stronger health beliefs. The scale demonstrates good internal consistency (Cronbach's Alpha = 0.87).

Baseline, immediately post-intervention, and 1-month follow-up.
Change in Smoking Refusal Self-Efficacy
Time Frame: Baseline, immediately post-intervention, and 1-month follow-up.
This study adapted the Chinese version of the General Self-Efficacy Scale (GSES) from Zhang JX, Schwarzer R, Jerusalem M (1995), consisting of 7 items. It uses a 5-point Likert scale, with higher scores indicating greater self-efficacy. The scale demonstrates excellent internal consistency (Cronbach's Alpha = 0.94).
Baseline, immediately post-intervention, and 1-month follow-up.
Extended Expectation Confirmation
Time Frame: Baseline, immediately post-intervention, and 1-month follow-up.
This study was adapted from scale items by Gupta et al. (2021), Moon & Kim (2001), and Venkatesh et al. (2012) to measure expectation confirmation regarding the e-cigarette prevention escape room game. It consists of 20 items using a 5-point Likert scale, with higher scores indicating greater expectation confirmation. The scale demonstrates excellent internal consistency (Cronbach's Alpha = 0.94).
Baseline, immediately post-intervention, and 1-month follow-up.
Learning Engagement
Time Frame: Immediately post-intervention.
This study was adapted from Zaichkowsky (1994) to assess participants' engagement level with the e-cigarette prevention escape room game. It includes two dimensions-"cognitive engagement" and "emotional engagement"-comprising 10 items total. The scale uses a 7-point Likert format, with higher scores indicating greater agreement. The scale demonstrates good internal consistency (Cronbach's Alpha = 0.83).
Immediately post-intervention.
Behavioral Intention
Time Frame: Immediately post-intervention.
This study's behavioral intention measurement tool aims to assess specific behaviors for actual e-cigarette prevention. It was revised after expert review and pilot testing to ensure applicability, validity, and reliability. The scale was evaluated by three experts for semantic clarity and contextual appropriateness, with wording refined post-pilot. It demonstrates good internal consistency reliability (Cronbach's α = 0.77), consists of 3 items using a 5-point Likert scale, with higher scores indicating greater likelihood of taking action.
Immediately post-intervention.
Advocacy Intention
Time Frame: Immediately post-intervention and 1-month follow-up.
This study's advocacy intention measurement tool aims to assess participants' willingness to promote e-cigarette prevention policies. It was revised after expert review and pilot testing to ensure applicability, validity, and reliability. The scale was evaluated by three experts for semantic clarity and contextual appropriateness, with wording refined post-pilot. It demonstrates good internal consistency reliability (Cronbach's α = 0.75), consists of 2 items using a 5-point Likert scale, with higher scores indicating greater likelihood of advocacy action.
Immediately post-intervention and 1-month follow-up.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jong-Long Guo, National Taiwan Normal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

March 5, 2026

First Submitted That Met QC Criteria

March 24, 2026

First Posted (Actual)

March 30, 2026

Study Record Updates

Last Update Posted (Actual)

March 30, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 202504HM004

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No IPD sharing planned due to small sample size (n=200 children), privacy concerns with pediatric participants, and limited resources for data repository management.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tobacco Use

Clinical Trials on Robot-assisted Immersive Escape Room Game

Subscribe